I read James Flanigan's Aug. 30 column about the cigarette industry, and I was appalled.
Why is it necessary to give an industry whose product is admittedly a serious health hazard so much of a boost? Flanigan's columns undoubtedly are meant as a guide for investor-readers, and he has in effect encouraged readers to invest in an industry whose products should be avoided.
